People · Operator

Mary Jane C. England

Named in public records as an officer, director or promoter · active 2011–2011 · Other Health Care

1
Companies
1
Filings
$5.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Healthways, IncOther Health CareSeries A$5.0M$100.9M2011
Operator network

Mary Jane C. England at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Stefen F. Brueckner · 2 companies · 1 sharedStefen F. Brueckn…THOMAS G. CIGARRAN · 2 companies · 1 sharedTHOMAS G. CIGARRANAlfred F. Lumsdaine · 1 companies · 1 sharedAlfred F. Lumsdai…Alison C. Taunton-Rigby · 1 companies · 1 sharedAlison C. Taunton…Anne M. Wilkins · 1 companies · 1 sharedAnne M. WilkinsBen R. Leedle, Jr. · 1 companies · 1 sharedBen R. Leedle, Jr.C. Warren Neal · 1 companies · 1 sharedC. Warren NealJay C. Bisgard · 1 companies · 1 sharedJay C. BisgardJohn A. Wickens · 1 companies · 1 sharedJohn A. WickensJohn W. Ballantine · 1 companies · 1 sharedJohn W. BallantineMatthew E. Kelliher · 1 companies · 1 sharedMatthew E. Kellih…William C. O'Neil, Jr. · 1 companies · 1 sharedWilliam C. O'Neil…William D. Novelli · 1 companies · 1 sharedWilliam D. NovelliHealthways, Inc · $5.0M raisedHealthways, IncMary Jane C. EnglandME
Mary Jane C. England Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Mary Jane C. England on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Stefen F. Brueckner12
THOMAS G. CIGARRAN12
William D. Novelli11
John A. Wickens11
Matthew E. Kelliher11
Alison C. Taunton-Rigby11
Alfred F. Lumsdaine11
John W. Ballantine11
Jay C. Bisgard11
Anne M. Wilkins11
William C. O'Neil, Jr.11
C. Warren Neal11
Ben R. Leedle, Jr.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.